RecruitingNot ApplicableNCT07642375

Study of the Impact of Digital Health Interventions on Symptom & Side-Effect Management in Metastatic Sarcoma Patients

Observational, Randomized, Prospective Study of the Impact of Digital Health Interventions on Symptom and Side-Effect Management in Patients With Metastatic Sarcoma

Sponsor

CareAcross

Enrollment

108 participants

Start Date

Aug 22, 2023

Study Type

INTERVENTIONAL

Conditions

Metastatic Sarcoma Advanced Sarcoma

Summary

The objective of this prospective study is to capture the quality of life of patients with locally advanced or metastatic sarcoma, and investigate the effectiveness of support provided through a personalized web-based platform.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called Digital support for people with advanced sarcoma and metastatic sarcoma. The study is currently recruiting participants at 11 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALDigital support

Personalized educational and supportive material, based on each patients' adverse events reported as PROs, delivered via the online platform.

Locations(11)

401 General Military Hospital

Athens, Greece

251 Air Force General Hospital

Athens, Greece

Attikon Hospital, 2nd clinic

Athens, Greece

Attikon Hospital, 4th clinic

Athens, Greece

Hygeia hospital

Athens, Greece

Mitera hospital

Athens, Greece

Metropolitan General Hospital

Athens, Greece

Ippokrateio General Hospital

Athens, Greece

Bioclinic

Thessaloniki, Greece

Ippokratio General Hospital of Thessaloniki

Thessaloniki, Greece

Papageorgiou General Hospital

Thessaloniki, Greece

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07642375

Related Trials

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

NCT0571161516 locations

Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

NCT041990261 location

Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma

NCT067965433 locations

Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors

NCT047715201 location

Safety and Feasibility of Intraoperative Visualization With Cytalux in Children

NCT062351251 location